Projected Income Statement: IBM

Forecast Balance Sheet: IBM

Forecast Balance Sheet - IBM
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 44,147 42,108 43,085 40,168 46,789 48,365 35,779 31,897
Change - -4.62% 2.32% -6.77% 16.48% 3.37% -26.02% -10.85%
Announcement Date 24/01/22 25/01/23 24/01/24 29/01/25 28/01/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: IBM

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 2,381 1,860 1,488 1,127 1,617 1,605 1,589 1,618
Change - -21.88% -20% -24.26% 43.48% -0.72% -0.99% 1.78%
Free Cash Flow (FCF) 1 6,508 9,291 11,210 12,749 14,734 15,619 16,959 18,633
Change - 42.76% 20.65% 13.73% 15.57% 6.01% 8.58% 9.87%
Announcement Date 24/01/22 25/01/23 24/01/24 29/01/25 28/01/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: IBM

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) - 24.35% 24.97% 26.13% 28.43% 28.77% 29.47% 29.74%
EBIT Margin (%) - 16.42% 17.87% 17.95% 20.92% 21.1% 21.83% 22.95%
EBT Margin (%) 8.43% 1.91% 14.05% 9.24% 15.29% 15.5% 17.68% 19.28%
Net margin (%) 10.01% 2.71% 12.13% 9.6% 15.69% 13.55% 15.25% 16.23%
FCF margin (%) 11.35% 15.35% 18.12% 20.32% 21.82% 22.14% 23.16% 24.13%
FCF / Net Income (%) 113.32% 566.87% 149.43% 211.67% 139.09% 163.4% 151.88% 148.65%

Profitability

        
ROA 3.99% 6.42% 5.73% 7.11% 7.61% 7.51% 7.44% 7.9%
ROE 36.33% 40.77% 33.79% 38.86% 36.67% 32.53% 30.25% 27.56%

Financial Health

        
Leverage (Debt/EBITDA) - 2.86x 2.79x 2.45x 2.44x 2.38x 1.66x 1.39x
Debt / Free cash flow 6.78x 4.53x 3.84x 3.15x 3.18x 3.1x 2.11x 1.71x

Capital Intensity

        
CAPEX / Current Assets (%) 4.15% 3.07% 2.41% 1.8% 2.39% 2.28% 2.17% 2.1%
CAPEX / EBITDA (%) - 12.62% 9.63% 6.87% 8.42% 7.91% 7.37% 7.05%
CAPEX / FCF (%) 36.59% 20.02% 13.27% 8.84% 10.97% 10.28% 9.37% 8.68%

Items per share

        
Cash flow per share 1 14.15 11.44 15.11 14.35 13.91 17.84 18.47 19.57
Change - -19.14% 32.08% -5.04% -3.06% 28.28% 3.54% 5.96%
Dividend per Share 1 6.55 6.52 6.63 6.67 6.71 6.763 6.82 6.951
Change - -0.46% 1.69% 0.6% 0.6% 0.79% 0.83% 1.93%
Book Value Per Share 1 21.09 24.31 24.63 29.48 34.84 40.64 47.11 54.67
Change - 15.24% 1.3% 19.71% 18.2% 16.62% 15.93% 16.05%
EPS 1 6.35 1.8 8.14 6.43 11.17 9.997 11.23 12.79
Change - -71.65% 352.22% -21.01% 73.72% -10.5% 12.33% 13.92%
Nbr of stocks (in thousands) 896,800 904,126 913,119 924,645 934,735 942,134 942,134 942,134
Announcement Date 24/01/22 25/01/23 24/01/24 29/01/25 28/01/26 - - -
1USD
Estimates
2026 *2027 *
P/E 25.2x 22.5x
PBR 6.2x 5.35x
EV / Sales 4.05x 3.73x
Yield 2.68% 2.71%

EPS & Dividend

EPS & Dividend - IBM


Y-o-Y evolution of P/E

Valuation ratios - P/E - IBM
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - IBM
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - IBM
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
252.11USD
Average target price
257.22USD
Spread / Average Target
+2.03%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - IBM